"My challenge is to drive sales growth of our products in a market gripped by two anti-growth forces: increasing competition and decreasing access to sales opportunities"- Trace Cawley, Sales & Marketing of Spinal Products at the Kyocera Medical Technologies, Inc. in Texas, U.S.A.
The U.S. orthopedic implants market makes up roughly 60% of the global market, comprising a large number of players with products becoming more commoditized.
KMTI is a U.S.-based company that develops and sells orthopedic implants such as spinal and joint implants. Kyocera has a rich history of developing advanced technologies that stand apart from competitors and open new market segments. KMTI is evaluating several advanced technologies that not only complement our existing products, but also open entirely new business segments which will allow us to grow rapidly, unchallenged, and with much greater profitability.
Learn more about KMTI here:
Learn more about Kyocera's operations in the medical and healthcare markets by watching the video below: